Sabra Health Care REIT (SBRA) Tops Q2 EPS by 9c, provides guidance

Sabra Health Care REIT (NASDAQ: SBRA) reported Q2 EPS of $0.27, $0.09 better than the analyst estimate of $0.18. Revenue for the quarter came in at $189.15 million versus the consensus estimate of $181.53 million.

GUIDANCE:

Sabra Health Care REIT sees FY2025 EPS of $0.77-$0.79, versus the consensus of $0.70.

For earnings history and earnings-related data on Sabra Health Care REIT (SBRA) click here.

You May Also Be Interested In

• Leerink Starts Parabilis Medicines (PBLS) at Outperform
• Evercore ISI Downgrades SL Green Realty (SLG) to In Line
• Leerink Starts Avalo Therapeutics Inc. (AVTX) at Outperform